VolitionRx Limited (AMEX:VNRX) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good morning, ladies and gentlemen, ...

Despite ongoing developments in head injury protocols, rugby union still faces challenges in achieving accurate, rapid and ...

This announcement has been reviewed by Dr. Gábor Bada, Falcon Oil & Gas Ltd’s Technical Advisor. Dr. Bada obtained his ...

Abingdon Health PLC (AIM:ABDX) executive chairman Dr Chris Hand talked with Proactive's Stephen Gunnion about the company’s ...

Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), a Canadian based, internationally focused energy transition ...

Archer Materials pivots to real-world markets, with Biochip-driven, quantitative, point-of-care potassium testing—potentially ...

HENDERSON, Nev., March 31, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has secured an additional €2.0 million (approximately $2.3 ...

Abingdon Health PLC on Monday said it had won a series of contracts with a US-based customer to develop, scale up, and manufacture several lateral flow devices measuring multiple biomarkers. The York, ...

Shares in Abingdon Health PLC (AIM:ABDX) rose 14% to 8.24p after the AIM-listed rapid diagnostic test developer announced contracts worth approximately £4.8 million to develop and scale up the ...

Abingdon Health, the York-based developer, manufacturer and regulatory services provider for rapid diagnostic tests and ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has received ...

Following the beginning of the COVID-19 outbreak, lateral flow assays (LFAs)—the category of test strips in which the ...